ABIO: 165% | ARCA Biopharma shares are trading higher after the company and Oruka Therapeutics announced a merger agreement.
LGVC: 193% | LAMF Global Ventures Corp. I Shareholders Approve Previously Announced Business Combination with Nuvo Group Ltd.
HSDT: 50% | Helius Medical Technologies, Inc. Announces Partnership with Lovell Government Services to Expand Reach of PoNS Therapy